These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 21248069)

  • 1. Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression.
    Li Y; Alsagabi M; Fan D; Bova GS; Tewfik AH; Dehm SM
    Cancer Res; 2011 Mar; 71(6):2108-17. PubMed ID: 21248069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression.
    Li Y; Hwang TH; Oseth LA; Hauge A; Vessella RL; Schmechel SC; Hirsch B; Beckman KB; Silverstein KA; Dehm SM
    Oncogene; 2012 Nov; 31(45):4759-67. PubMed ID: 22266865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.
    Dehm SM; Schmidt LJ; Heemers HV; Vessella RL; Tindall DJ
    Cancer Res; 2008 Jul; 68(13):5469-77. PubMed ID: 18593950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.
    Nyquist MD; Li Y; Hwang TH; Manlove LS; Vessella RL; Silverstein KA; Voytas DF; Dehm SM
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17492-7. PubMed ID: 24101480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.
    Marcias G; Erdmann E; Lapouge G; Siebert C; Barthélémy P; Duclos B; Bergerat JP; Céraline J; Kurtz JE
    Hum Mutat; 2010 Jan; 31(1):74-80. PubMed ID: 19830810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternatively spliced androgen receptor variants.
    Dehm SM; Tindall DJ
    Endocr Relat Cancer; 2011 Oct; 18(5):R183-96. PubMed ID: 21778211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.
    Karacosta LG; Foster BA; Azabdaftari G; Feliciano DM; Edelman AM
    J Biol Chem; 2012 Jul; 287(29):24832-43. PubMed ID: 22654108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal.
    Chan SC; Li Y; Dehm SM
    J Biol Chem; 2012 Jun; 287(23):19736-49. PubMed ID: 22532567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
    Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
    J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor gene rearrangements: new perspectives on prostate cancer progression.
    Brand LJ; Dehm SM
    Curr Drug Targets; 2013 Apr; 14(4):441-9. PubMed ID: 23410127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.
    Guo Z; Yang X; Sun F; Jiang R; Linn DE; Chen H; Chen H; Kong X; Melamed J; Tepper CG; Kung HJ; Brodie AM; Edwards J; Qiu Y
    Cancer Res; 2009 Mar; 69(6):2305-13. PubMed ID: 19244107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression.
    Nyquist MD; Dehm SM
    Horm Cancer; 2013 Apr; 4(2):61-9. PubMed ID: 23307762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities.
    Hu R; Isaacs WB; Luo J
    Prostate; 2011 Nov; 71(15):1656-67. PubMed ID: 21446008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.
    Watson PA; Chen YF; Balbas MD; Wongvipat J; Socci ND; Viale A; Kim K; Sawyers CL
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16759-65. PubMed ID: 20823238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortened isoforms of the androgen receptor are regulated by the cytoprotective heat-shock protein HSPB1 and the tumor-suppressive microRNA miR-1 in prostate cancer cells.
    Stope MB; Bradl J; Peters S; Streitbörger A; Weiss M; Zimmermann U; Walther R; Lillig CH; Burchardt M
    Anticancer Res; 2013 Nov; 33(11):4921-6. PubMed ID: 24222130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative analysis of AR-mediated transcriptional regulatory network reveals IRF1 as an inhibitor of prostate cancer progression.
    Cheng Y; Wang D; Jiang J; Huang W; Li D; Luo J; Gu W; Mo W; Wang C; Li Y; Gu S; Xu Y
    Prostate; 2020 May; 80(8):640-652. PubMed ID: 32282098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.
    Hu R; Dunn TA; Wei S; Isharwal S; Veltri RW; Humphreys E; Han M; Partin AW; Vessella RL; Isaacs WB; Bova GS; Luo J
    Cancer Res; 2009 Jan; 69(1):16-22. PubMed ID: 19117982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancer.
    Wu K; Gore C; Yang L; Fazli L; Gleave M; Pong RC; Xiao G; Zhang L; Yun EJ; Tseng SF; Kapur P; He D; Hsieh JT
    Mol Endocrinol; 2012 Sep; 26(9):1496-507. PubMed ID: 22745193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Origin, Expression Regulation, and Biological Function of Androgen Receptor Splicing Variant 7 in Prostate Cancer.
    Chen Y; Lan T
    Urol Int; 2021; 105(5-6):337-353. PubMed ID: 32957106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.
    Bohrer LR; Liu P; Zhong J; Pan Y; Angstman J; Brand LJ; Dehm SM; Huang H
    Prostate; 2013 Jul; 73(10):1017-27. PubMed ID: 23389878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.